Value in Health. ISPOR 11th Annual European Congress Research Abstracts

Once daily mesalazine for maintaining remission is cost-saving compared to twice daily mesalazine: an economic evaluation based on the PODIUM randomised controlled trial

http://onlinelibrary.wiley.com/doi/10.1111/j.1524-4733.2008.00453_2.x/abstract

Post author By Connolly M P, Nielsen S K, Currie C J and Poole C D
Post date 14 October 2008

Connolly M, Nielsen S K, Currie C J, Poole C D. 14 Oct 2008

Connolly M P

Nielsen S K

Currie C J

Poole C D

Transforming real-world data into transparent, reliable, and reliable real-world evidence

44 (0) 2920 782856

enquiries@humandatasciences.com

24 Wordsworth Avenue, Cardiff, CF24 3FR United Kingdom

Copyright Pharmatelligence Limited (trading as Human Data Sciences) is a Private Limited Company (PLC) registered in England and Wales with Company Number 7107514.

Livingstone® is a Trusted Research Environment (TRE)

Quick Links

Transforming real-world data into transparent, reliable, and replicable real-world evidence

44 (0) 2920 782856

instantRWE@humandatasciences.com

The Global Pharma Research Centre,
24 Wordsworth Avenue, Cardiff, CF24 3FR United Kingdom

Copyright Pharmatelligence Limited (trading as Human Data Sciences) is a Private Limited Company (PLC) registered in England and Wales with Company Number 7107514.

Livingstone^® is a Trusted Research Environment (TRE)

Web Design – Create Summit

Site by Create Summit